Numab Therapeutics Ag

Numab Therapeutics is a biopharmaceutical company focused on the discovery and development of next-generation multispecific antibody-based therapeutics for inflammation and oncology. With over a decade of innovation, Numab has built a highly differentiated multispecific antibody platform integrating λ-cap™ and MATCH™ technologies, advanced Fc engineering, and integrated immunogenicity-reduction strategies. Leveraging deep in-house engineering expertise, Numab is advancing a diversified pipeline of multispecific antibodies with first- and best-in-class potential and has established a strong track record of strategic partnerships with leading pharmaceutical companies.